![Development and Validation of a Short Version of the Kansas City Cardiomyopathy Questionnaire | Circulation: Cardiovascular Quality and Outcomes Development and Validation of a Short Version of the Kansas City Cardiomyopathy Questionnaire | Circulation: Cardiovascular Quality and Outcomes](https://www.ahajournals.org/cms/asset/0258e37f-4bb3-4035-a267-d85f55087792/469fig01.jpg)
Development and Validation of a Short Version of the Kansas City Cardiomyopathy Questionnaire | Circulation: Cardiovascular Quality and Outcomes
![JCM | Free Full-Text | Assessment of Physical Activity Using Waist-Worn Accelerometers in Hospitalized Heart Failure Patients and Its Relationship with Kansas City Cardiomyopathy Questionnaire JCM | Free Full-Text | Assessment of Physical Activity Using Waist-Worn Accelerometers in Hospitalized Heart Failure Patients and Its Relationship with Kansas City Cardiomyopathy Questionnaire](https://pub.mdpi-res.com/jcm/jcm-10-04103/article_deploy/html/images/jcm-10-04103-g001.png?1631592639)
JCM | Free Full-Text | Assessment of Physical Activity Using Waist-Worn Accelerometers in Hospitalized Heart Failure Patients and Its Relationship with Kansas City Cardiomyopathy Questionnaire
![Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure | Journal of the American College of Cardiology Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/16842706-1c35-4ba2-ae68-ed4f40f372e3/gr1.gif)
Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure | Journal of the American College of Cardiology
![Links To And Excerpts From "Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care: JACC State-of-the-Art Review" - Tom Wade MD Links To And Excerpts From "Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care: JACC State-of-the-Art Review" - Tom Wade MD](https://tomwademd.net/wp-content/uploads/2021/11/fig1-9.png)
Links To And Excerpts From "Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care: JACC State-of-the-Art Review" - Tom Wade MD
![Psychometric properties of the Japanese version of the Kansas City Cardiomyopathy Questionnaire in Japanese patients with chronic heart failure | Health and Quality of Life Outcomes | Full Text Psychometric properties of the Japanese version of the Kansas City Cardiomyopathy Questionnaire in Japanese patients with chronic heart failure | Health and Quality of Life Outcomes | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12955-020-01483-0/MediaObjects/12955_2020_1483_Fig1_HTML.png)
Psychometric properties of the Japanese version of the Kansas City Cardiomyopathy Questionnaire in Japanese patients with chronic heart failure | Health and Quality of Life Outcomes | Full Text
![Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care: JACC State-of-the-Art Review | Journal of the American College of Cardiology Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care: JACC State-of-the-Art Review | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/eadec44b-f08d-4341-9893-108a14fcb359/gr1.jpg)
Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care: JACC State-of-the-Art Review | Journal of the American College of Cardiology
![Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care: JACC State-of-the-Art Review - ScienceDirect Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care: JACC State-of-the-Art Review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109720372326-gr3.jpg)
Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care: JACC State-of-the-Art Review - ScienceDirect
![Development and Validation of a Short Version of the Kansas City Cardiomyopathy Questionnaire | Circulation: Cardiovascular Quality and Outcomes Development and Validation of a Short Version of the Kansas City Cardiomyopathy Questionnaire | Circulation: Cardiovascular Quality and Outcomes](https://www.ahajournals.org/cms/asset/12b360fd-a45d-43a8-b898-b884e697cd38/469fig01.jpeg)
Development and Validation of a Short Version of the Kansas City Cardiomyopathy Questionnaire | Circulation: Cardiovascular Quality and Outcomes
![Development and Validation of a Short Version of the Kansas City Cardiomyopathy Questionnaire. - Abstract - Europe PMC Development and Validation of a Short Version of the Kansas City Cardiomyopathy Questionnaire. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4885562/bin/hcq-8-469-g001.jpg)
Development and Validation of a Short Version of the Kansas City Cardiomyopathy Questionnaire. - Abstract - Europe PMC
![Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care: JACC State-of-the-Art Review | Journal of the American College of Cardiology Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care: JACC State-of-the-Art Review | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/c52d923e-283a-4d82-96c0-6ad3b8649fa9/gr2.jpg)
Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care: JACC State-of-the-Art Review | Journal of the American College of Cardiology
Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction
Kansas City Cardiomyopathy Questionnaire Incompletely Captures Symptoms in Patients with Hypertrophic Cardiomyopathy
![Which patients with heart failure should receive specialist palliative care? - Campbell - 2018 - European Journal of Heart Failure - Wiley Online Library Which patients with heart failure should receive specialist palliative care? - Campbell - 2018 - European Journal of Heart Failure - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/bf09d3ad-0a02-4242-a7f7-fbe1e8c4d3b1/ejhf1240-fig-0001-m.jpg)
Which patients with heart failure should receive specialist palliative care? - Campbell - 2018 - European Journal of Heart Failure - Wiley Online Library
![Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care: JACC State-of-the-Art Review - ScienceDirect Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care: JACC State-of-the-Art Review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109720372326-fx1.jpg)